omniture
Brexogen Inc.,

Latest News

Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA

First entry to clinical trial of exosome for atopic dermatitis The first exosome-based therapeutic...

2022-11-07 07:00 2233